Emil Hensel files SEC Form 4 disclosures for CROSS COUNTRY HEALTHCARE INC. They have made 7 open-market trades across 1 company since 2006, most recently 2014-09-26.
CIK 0001179743
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $48K since 2012, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CCRN | 85,775 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2014-09-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCRN | SELL | 2014-09-26 | 2014-09-30 | $9.11 | $64K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL | 2014-09-10 | 2014-09-12 | $8.92 | $45K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL | 2014-08-13 | 2014-08-13 | $7.98 | $40K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL | 2014-07-28 | 2014-07-30 | $7.22 | $67K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL | 2014-06-05 | 2014-06-06 | $6.75 | $20K | -17.7% | -4.0% | -4.0% |
| CCRN | BUY | 2012-05-23 | 2012-05-25 | $3.97 | $48K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2008-09-10 | 2008-09-11 | $16.90 | $237K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL | 2008-08-14 | 2008-08-18 | $16.82 | $84K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2007-10-05 | 2007-10-09 | $18.99 | $57K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2007-09-19 | 2007-09-21 | $18.99 | $19K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2007-01-11 | 2007-01-16 | $22.99 | $307K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2006-12-27 | 2006-12-29 | $22.21 | $769K | -17.7% | -4.0% | -4.0% |
| CCRN | SELL · 10b5-1 | 2006-12-14 | 2006-12-18 | $21.52 | $172K | -17.7% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.